SATO, MARCELO C.PIETRO, EMILENE C.I.N.ALVES, LUCAS M. de C.KRAMER, AXELSANTOS, PAULO S. da S.2023-12-052023-12-052023SATO, MARCELO C.; PIETRO, EMILENE C.I.N.; ALVES, LUCAS M. de C.; KRAMER, AXEL; SANTOS, PAULO S. da S. Candida auris: a novel emerging nosocomial pathogen – properties, epidemiological situation and infection control. <b>GMS Hygiene and Infection Control</b>, v. 18, p. 1-7, 2023. DOI: <a href="https://dx.doi.org/10.3205/dgkh000444">10.3205/dgkh000444</a>. Disponível em: http://repositorio.ipen.br/handle/123456789/34239.2196-5226http://repositorio.ipen.br/handle/123456789/34239Immunosuppression and critical illnesses in combination with ecological imbalance open the door for novel opportunistic fungal infections, as in case of Candida (C). auris. C. auris has emerged globally as a multidrug-resistant yeast, causing infections and outbreaks in health care facilities. This narrative review discusses the properties of the yeast, the development of the epidemiological situation, the nosocomial spread and causes for nosocomial outbreaks triggered by C. auris in the hospital environment, and summarizes international recommendations for infection control, supplemented by suggestions on diagnostic, screening and antibiotic stewardship.1-7openAccesscandidainfectious diseasesepidemiologyyeastsantibioticsArtigo de periódico1810.3205/dgkh00044435.6Sem Percentil CiteScore